EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harnessing explainable artificial intelligence for patient-to-clinical-trial matching: A proof-of-concept pilot study using phase I oncology trials

Satanu Ghosh, Hassan Mohammed Abushukair iD, Arjun Ganesan, Chongle Pan, Abdul Rafeh Naqash, Kun Lu iD

PLOS ONE · 24.10.2024 · 19 (10) · e0311510

DOI: 10.1371/journal.pone.0311510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 24.10.2024. Verfasst von Satanu Ghosh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, University of New Hampshire, Durham, New Hampshire, United States of America. Hauptthemen laut MEDLINE: Artificial Intelligence, Natural Language Processing, Clinical Trials, Phase I as Topic, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oklahoma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to develop explainable AI methods for matching patients with phase 1 oncology clinical trials using Natural Language Processing (NLP) techniques to address challenges in patient recruitment for improved efficiency in drug development. A prototype system based on modern NLP techniques has been developed to match patient records with phase 1 oncology clinical trial protocols. Four criteria are considered for the matching: cancer type, performance status, genetic mutation, and measurable disease. The system outputs a summary matching score along with explanations of the evidence. The outputs of the AI system were evaluated against the ground truth matching results provided by the domain expert on a dataset of twelve synthesized dummy patient records and six clinical trial protocols. The system achieved a precision of 73.68%, sensitivity/recall of 56%, accuracy of 77.78%, and specificity of 89.36%. Further investigation into the misclassified cases indicated that ambiguity of abbreviation and misunderstanding of context are significant contributors to errors. The system found evidence of no matching for all false positive cases. To the best of our knowledge, no system in the public domain currently deploys an explainable AI-based approach to identify optimal patients for phase 1 oncology trials. This initial attempt to develop an AI system for patients and clinical trial matching in the context of phase 1 oncology trials showed promising results that are set to increase efficiency without sacrificing quality in patient-trial matching.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceNatural Language ProcessingClinical Trials, Phase I as TopicNeoplasmsHumansPilot ProjectsProof of Concept StudyPatient SelectionMedical Oncology

Autor:innen und Institutionen

  • Department of Computer Science, University of New Hampshire, Durham, New Hampshire, United States of America.
  • Jordan University of Science and Technology, Irbid, Jordan.
  • School of Computer Science, University of Oklahoma Norman Campus, Norman, Oklahoma, United States of America.
  • Medical Oncology/ TSET Phase 1 Program, Stephenson Cancer Center, The University of Oklahoma Health Science Campus, Oklahoma City, Oklahoma, United States of America.
  • School of Library and Information Studies, University of Oklahoma Norman Campus, Norman, Oklahoma, United States of America.

ORCID-Profile: Hassan Mohammed Abushukair, Kun Lu

Förderung

  • University of Oklahoma

Zitieren

APA

Ghosh, S., Abushukair, H. M., Ganesan, A., Pan, C., Naqash, A. R., & Lu, K. (2024). Harnessing explainable artificial intelligence for patient-to-clinical-trial matching: A proof-of-concept pilot study using phase I oncology trials. PLOS ONE, 19(10), e0311510. https://doi.org/10.1371/journal.pone.0311510

Vancouver

Ghosh S, Abushukair HM, Ganesan A, Pan C, Naqash AR, Lu K. Harnessing explainable artificial intelligence for patient-to-clinical-trial matching: A proof-of-concept pilot study using phase I oncology trials. PLOS ONE. 2024;19(10):e0311510. doi:10.1371/journal.pone.0311510

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Satanu and Abushukair, Hassan Mohammed and Ganesan, Arjun and Pan, Chongle and Naqash, Abdul Rafeh and Lu, Kun},
  title = {Harnessing explainable artificial intelligence for patient-to-clinical-trial matching: A proof-of-concept pilot study using phase I oncology trials},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {10},
  pages = {e0311510},
  doi = {10.1371/journal.pone.0311510}
}
Kostenlos starten →